SYMPLEX™ Drug Discovery Platform
SYMPLEX™ is a self-renewing discovery engine that generates, screens, and optimizes MYC-SL drug candidates with novel mechanisms.
-
GUNS-DF (General utility new scaffold-drug fragment)
Diverse and regenerative chemical scaffolds and fragments tailored to MYC biology -
MIPS (Mechanism-Informed Phenotypic Screening)
Systematic cancer cell survival dependency and phenotypic analysis technology -
DrugGPT (An AI Drug Discovery & Integration System)
Integration and analysis of generated biological and chemical structure data to optimize next-generation molecules
Systematic discovery of MYC-SL drug candidates through:
-
Design: Rational compound design across diverse scaffolds
-
Test: Biological screening in MYC-relevant systems
-
Learn: Data-driven optimization and mechanism refinement
-
Outcome: Discovery of compounds with mechanisms distinct from prior MYC approaches
Biological Phenotype Output
